Phase II randomized trial of radiation therapy, cetuximab, and pemetrexed with or without bevacizumab in patients with locally advanced head and neck cancerAthanassios Argiris, Robert L. Ferris, Julie E. Bauman et al.|Annals of Oncology|2016Cited by 49
In Situ Quantitative Measurement of HER2mRNA Predicts Benefit from Trastuzumab-Containing Chemotherapy in a Cohort of Metastatic Breast Cancer PatientsMaria Vassilakopoulou, Amanda Psyrri, Mattheos Bobos et al.|PLoS ONE|2014Cited by 27
In situ quantitative measurement of mRNA to predict response to trastuzumab in a cohort of metastatic breast cancer patients.Maria Vassilakopoulou, Amanda Psyrri, Jennifer Bordeaux et al.|Journal of Clinical Oncology|2012Cited by 0